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Atrazine (ATZ; 2-chloro-4-ethylamino-6-
isopropylamino-s-triazine) is a systemic tri-
azine herbicide that blocks photosynthesis
in broadleaf weeds and some grassy weeds
(Laws and Hayes 1991). ATZ is currently
one of the two most widely used agricultural
pesticides in the United States, although
from 1985 to 2001, it was the most abun-
dantly applied pesticide (Donaldson et al.
2002; Kiely et al. 2004). Approximately
64–80 million pounds of ATZ are applied
annually in the United States for agricul-
tural and residential purposes; this amount
has remained relatively constant over the
past few decades (Kiely et al. 2004).
ATZ has been used predominantly in the
Midwest (Nelson et al. 2001). About three-
fourths of all field corn and sorghum are
treated with ATZ annually for weed control.
Seventy percent of the ATZ applied to corn
and sorghum is used as a preemergence herbi-
cide, and 30% is applied postemergence.
ATZ is also used for weed control in sugar-
cane and wheat ﬁelds. In addition to agricul-
tural uses, ATZ is used in residential turf
applications in the Southeast, including use
on golf courses and sod farms to control
weeds (Nelson et al. 2001).
ATZ and its degradates are the most com-
monly detected pesticide(s) in ground and
surface waters (Aaronson et al. 1980; Appel
and Hudak 2001; Barbash et al. 2001; Barnes
and Kalita 2001; Battaglin et al. 2000;
Bushway et al. 1992; Clark and Clay et al.
2000; Goolsby 2000; Gaynor et al. 2002). It
has been the subject of multiple monitoring
programs conducted by various industry and
government agencies, especially the U.S.
Geological Survey (USGS) (Barbash et al.
2001). The frequent detection of ATZ and its
degradates in streams, rivers, groundwater,
and reservoirs is related directly to its volume
of use, its tendency to persist in soils because
of its resistance to photolysis and hydrolysis,
and its ability to travel with water systems
(Nelson et al. 2001). In water systems, ATZ
typically undergoes dealkylation to form
desethylatrazine (DEA), desisopropylatrazine
(DIA), and the terminal dealklylation prod-
uct diaminochlorotriazine (DACT) (Nelson
et al. 2001) (Figure 1). In plants, ATZ is
absorbed by the root system and tends to
form hydroxylated metabolites that cannot
generally be removed by washing of the veg-
etable products. Studies reported to the U.S.
Environmental Protection Agency (EPA) have
suggested that in animals the degradation
products that retain the chlorine have biologi-
cal activity similar to that of atrazine, whereas
the hydroxylated metabolites do not retain
their biological activity (Nelson et al. 2001).
The biological end points observed in animals
have been primarily endocrine-mediated, for
example, affecting hypothalamic control of
pituitary–ovarian function by modulation of
luteinizing hormone release (Cooper et al.
2000; Gojmerac et al. 2004; McMullin et al.
2004) and mammary tumor production
(Eldridge et al. 1994, 1999; O’Connor et al.
2000; Ueda et al. 2005; Wetzel et al. 1994).
ATZ has also been reported to modulate aro-
matase activity in vivo and in vitro (Crain
et al. 1997; Hecker et al. 2004) potentially
resulting in hermaphroditic amphiphibians
(Hayes et al. 2002), although this health out-
come has been debated (Gammon et al. 2005;
Renner 2002). 
Metabolism of ATZ and its degradation
products is a complex process resulting in
multiple potential metabolites (Figure 1).
Many human and animal studies have evalu-
ated ATZ metabolism and the conclusions
are variable (Table 1). Some rat and human
studies identified DACT as the primary
metabolite of ATZ (Bakke et al. 1972;
Catenacci et al. 1990, 1993). Other human
studies identiﬁed atrazine mercapturate (AM)
(Figure 1), a glutathione-derived metabolite,
as the predominant metabolite (Buchholz
et al. 1999; Lucas et al. 1993; Perry et al.
2000). In total, 8–12 ATZ metabolites have
been identified or postulated (Bakke et al.
1972; Buchholz et al. 1999; Catenacci et al.
1990, 1993; Perry et al. 2000). 
The latter human studies led us to focus
our efforts mainly on measuring AM during
biomontoring in the pilot phase of the
Agricultural Health Study (ca. 1994; Alavanja
et al. 1996). AM was frequently detected in
the urine of farmer applicators, their spouses,
and sometimes children, typically at the high-
est concentrations on the day after ATZ appli-
cation (WJ Driskell, unpublished data, 1995).
Subsequently, we began measuring AM to
evaluate environmental exposures to ATZ;
however, this approach limited our ability to
detect total exposure to ATZ-related com-
pounds. In the Centers for Disease Control
and Prevention (CDC) National Report on
Human Exposure to Environmental Chemicals
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BACKGROUND: Atrazine (ATZ) is the second most abundantly applied pesticide in the United
States. When we assessed exposure to ATZ by measuring its urinary mercapturic acid metabolite,
general population data indicated that < 5% of the population was exposed to ATZ-related chemi-
cals (limit of detection < 0.8 ng/mL).
OBJECTIVES: The aim of our study was to determine if we were underestimating ATZ exposure by
measuring its urinary mercapturic acid metabolite and if the urinary metabole profile changed
with the exposure scenario.
METHODS: We conducted a small-scale study involving 24 persons classiﬁed as high- (n = 8), low-
(n = 5), and environmental- (n = 11) exposed to ATZ. Using online solid phase extraction high
performance liquid chromatography–tandem mass spectrometry, we measured nine ATZ-related
metabolites in urine that included dealkylated, hydroxylated, and mercapturic acid metabolites.
RESULTS: We found that the urinary metabolite proﬁles varied greatly among exposure scenarios
and among persons within each exposure scenario. Although diaminochlorotriazine (DACT)
appeared to be the predominant urinary metabolite detected in each exposure category, the varia-
tion in proportion of total ATZ metabolites among persons was consistently large, suggesting that
one metabolite alone could not be measured as a surrogate for ATZ exposure.
CONCLUSIONS: We have likely been underestimating population-based exposures by measuring
only one urinary ATZ metabolite. Multiple urinary metabolites must be measured to accurately
classify exposure to ATZ and its environmental degradates. Regardless, DACT and desethyla-
trazine appear to be the most important metabolites to measure to evaluate exposures to
ATZ-related chemicals.
KEY WORDS: atrazine, chlorotriazines, environmental, exposure assessment. Environ Health Perspect
115:1474–1478 (2007). doi:10.1289/ehp.10141 available via http://dx.doi.org/ [Online 18 July 2007](CDC 2001, 2003, 2005), AM, the only ATZ
metabolite measured, was typically detected in
< 5% of participants, which did not corre-
spond with its widespread use and frequent
detection in ground, surface, and municipal
water systems. Similarly, other studies reported
low frequencies of detection (e.g., < 3%) of
AM (Adgate et al. 2001; Lioy et al. 2000;
MacIntosh et al. 1999), even though one of
these studies reported frequent detection of
ATZ in homes (Lioy et al. 2000). 
The objective of our study was to evalu-
ate multiple metabolites of ATZ in persons
exposed in occupational and environmental
scenarios. We wanted to determine if meas-
urement of one metabolite was sufﬁcient to
estimate ATZ exposure relative to that in
other individuals or whether multiple chemi-
cals must be measured to accurately assess
exposure to ATZ.
Experiment
A detailed description of the analytical
method can be found in Panuwet et al. (in
press). Briefly, we introduced 200 µL urine
onto a dual online solid-phase extraction
(reversed-phase phenyl–hexyl and strong
cation exchange) system, which was operated
by a novel switching mechanism. Analytes
were preconcentrated using high-perfor-
mance liquid chromatography on a guard
column, and the remaining urine compo-
nents were washed off, using 10% methanol
in 0.1% formic acid, into a waste container.
The valves were switched, and the analytes
were backwashed onto a reversed-phase or
strong anion exchange analytic column and
separated using a linear gradient beginning
with 10% methanol in 0.1% formic acid and
ending with 100% methanol. Samples were
analyzed using atmospheric pressure chemical
ionization–tandem mass spectrometry with
one precursor–product ion pair being used
for quantiﬁcation and two precursor–product
ion pairs being used for confirmation
(Table 2). Quantiﬁcation was achieved using
isotope dilution calibration, for which iso-
topically labeled standards were available.
When they were not available, the most
closely eluting labeled standard was used for
quantiﬁcation. Each analytical run consisted
of a full eight-standard calibration set, three
positive (i.e., fortiﬁed urine samples at three
levels spanning calibration range) and two
negative (i.e., blank) control samples, and up
to 75 unknown samples. The limits of detec-
tion ranged from 0.1 to 1 ng/mL, with rela-
tive standard deviations typically < 12% over
the calibration range.
Human samples were collected from resi-
dential turf applicators (i.e., commercial lawn
care applicators), nonapplicators with low-
level exposures (i.e., nonoccupationally
exposed individuals with documented ATZ
exposure based upon detectable levels of AM
in their urine) and volunteers in Georgia with
no known acute exposure to ATZ. All sam-
ples were collected as part of previous studies
and were reanalyzed to determine total
metabolites. All protocols were reviewed and
approved by the CDC Institutional Review
Board for ethical treatment of human research
subjects. Samples were stored at –70°C until
used and before analysis were thawed at room
temperature and mixed thoroughly.
Simple statistics (mean, standard devia-
tion, and ratios) were performed using Excel
software (Microsoft, San Jose, CA). Because
the number of samples tested was small, no
signiﬁcance testing was performed.
Atrazine exposure
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Table 1. Summary of animal and human metabolite studies.a
Study Model DACT DIA DEA AM ATZ DAtM ATZ-OH Ammeline
Novartisb Rat 1 Minor Minor ND ND 1 ND ND
Bakke (Bakke Rat ND 1 1 ND ND ND 1 1
et al. 1972)
R. Bradwayb Rat 1 1 1 NA NA NA 1 1
Ericksonb Swine NA NA 1 NA NA NA NA NA
Novartisb Monkey 1 4 2 3 ND After iv ND ND
Catenacci Human 1 Minor Minor NA Minor NA NA NA
(Catenacci
et al. 1993)
Lucas (Lucas Human (D) Minor Minor Minor 1 NA NA NA NA
et al. 1993)
Buchholz Human (D) 2? Minor NA 1 NA 2? NA NA
(Buchholz
et al. 1999)
Perry (Perry  Human NA NA 2 1 NA NA NA NA
et al. 2000)
Catenacci Human 1 Minor 2 NA Minor NA NA NA
(Catenacci 
et al. 2002)
Abbreviations: AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DATM,
diaminotriazine mercapturate; DEA, desethylatrazine; DIA, desisopropyl atrazine; ND, not detected; NA, not measured or
applicable to the study; ?, metabolite with tentative identiﬁcation; (D), dermal exposure. “After iv” indicates that metabo-
lite was seen only after iv administration of atrazine.
a1, a major metabolite; 2, a less abundant metabolite; minor, minor metabolite identiﬁed. bInformation obtained from docu-
mentation of internal studies conducted at Novartis. Information was kindly supplied by Novartis upon request by CDC. 
Figure 1. Proposed metabolism of ATZ. ATZ is shown in black; dealkylated metabolites are shown in green;
hydroxylated metabolites are shown in blue; and glutathione-derived mercapturic acid metabolites are
shown in red. Abbreviations: ATZ, atrazine; ATZ-OH, hydroxyatrazine; AM, atrazine mercapturate; DACT,
diaminochlorotriazine; DATM, diaminotriazine mercapturate; DEA, desethylatrazine; DEAM, desethyla-
trazine mercapturate; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIAM, desisopropyla-
trazine mercapturate. 
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A mass chromatogram of a spiked urine sam-
ple is shown in Figure 2. Because the most
polar analytes were not adequately retained
on the reversed-phase column, a strong
cation exchange column was used. DACT
was partially retained on the reversed-phase
column, and the remainder was retained on
the strong cation exchange column resulting
in two peaks for DACT. Both peaks were
summed to calculate the total amount of
DACT present. All peaks were resolved by
either time or mass-to-charge ratio.
The metabolite profile of the higher
exposure category of turf applicators is
shown in Figure 3 (n = 8). The two graphs
represent the exposure assessment using only
AM and the exposure assessment using all
metabolites. DACT was the most predomi-
nantly detected metabolite (mean = 51%),
followed closely by DEA (mean = 31%). AM
was detected on average in only 12% of the
samples tested. The interperson variation
(calculated as the relative standard deviation
of the percentage of each metabolite percent-
age among persons) in urinary concentra-
tions among these most detected analytes
was between 33 and 51%. The interperson
variability was much greater for the less fre-
quently detected metabolites.
The metabolite profiles for the lower-
level exposure category (n = 5) are shown in
Figure 4. On average, DEA (33%) and
DACT (28%) were detected in about equal
proportions, with only 6% detection of AM.
Similar to the higher-level exposures, the
interperson variation in their urinary concen-
trations was large.
For the environmental exposure category,
DACT was by far the most predominantly
detected metabolite (77%). DEA was
detected the next most frequently (15%) and
AM was detected in only 2% of the samples.
Again, the interperson variability in meta-
bolic proﬁle concentrations was large.
Discussion
The small amount of data that we present
here clearly demonstrate that exposure to
ATZ-related chemicals can be misrepre-
sented by measurement of AM alone.
However, it is important to note that the
measurement of ATZ or AM in urine would
be the only unequivocal indication that a
person was exposed to ATZ and not an
environmental degradate.
Also, the metabolite profiles differ dra-
matically based upon the exposure scenario
(Figure 5). Occupational or lower-level acute
exposures, perhaps after ATZ use on lawns,
are probably more likely to be direct expo-
sures to ATZ and lesser exposures to the
degradation products. However, the environ-
mental exposure scenario is quite different.
In environmental exposures, persons likely
are exposed through food or water, which
would mean that dealkylation and hydrolysis
products might make up a larger percentage
of the exposure. Of course, exposure to the
dealkylation products is still important
Barr et al.
1476 VOLUME 115 | NUMBER 10 | October 2007 • Environmental Health Perspectives
Figure 2. Mass chromatogram of metabolites measured. AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH,
hydroxyatrazine; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEAM, desethylatrazine mercap-
turate; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIA-OH, hydroxydesisopropylatrazine;
SCX, strong cation exchange.
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Figure 3. Metabolite proﬁle of turf applicators using just AM and multiple metabolites. AM, atrazine mer-
capturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DEA, desethylatrazine;
DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine.
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Figure 4. Metabolite profile of lower level exposures using AM and multiple metabolites. Abbreviations:
AM, atrazine mercapturate; ATZ, atrazine; ATZ-OH, hydroxyatrazine; DACT, diaminochlorotriazine; DEA,
desethylatrazine; DEA-OH, hydroxydesethylatrazine; DIA, desisopropyl atrazine; DIA-OH, hydroxydesiso-
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Table 2. Precursor–product ion pairs for tandem
mass spectrometry of each analyte.a
Precursor Product  ions
Compound ion [M+H] Q C1 C2
ATZ-OH 198 86 156 69
DACT 146 79 68 62
DEAM 315 185 144 102
DIA 174 68 132 104
DEA 188 146 104 110
AM 343 214 102 172
ATZ 216 174 104 68
Abbreviations: AM, atrazine mercapturate; ATZ-OH, hydrox-
yatrazine; ATZ, atrazine; C1, conﬁrmation ion 1; C2, conﬁr-
mation ion 2; [M+H], pseudomolecular ion derived from
atmospheric pressure chemical ionization; DACT,
diaminochlorotriazine; DATM, diaminotriazine mercap-
turate; DEA, desethylatrazine; DEAM, desethylatrazine mer-
capturate; DIA, desisopropyl atrazine; Q, quantiﬁcation ion.
aMore details on the method are found in Panuwet et al.
(in press).because these chemicals remain biologically
active. Thus, the presence of the chlorinated
dealkylation products or their glutathione-
mediated mercapturic acid metabolites
would indicate exposure to a biologically
active component. Presence of the hydroxy-
lated metabolites may indicate exposure to
the hydroxylated products themselves or to
their chlorinated counterparts.
Our data demonstrate that we likely will
need to measure most or all metabolites of
ATZ to accurately assess ATZ-related expo-
sures. However, further evaluation is neces-
sary because of our small sample size and
because the possible presence of glucuronide
metabolites was not considered. In the
future, we will explore further the role of
hydroxyl metabolites in the metabolite pro-
files by evaluating glucuronide-hydrolyzed
urine. Also, we need to include the mercap-
turates of the dealkylation products in our
methodology to glean the full picture of
ATZ metabolism. Futhermore, we will use
this method to evaluate larger populations
with high-level occupational exposures (e.g.,
manufacturers, farmers) and background
exposures in the general U.S. population.
Although we found detectable concentra-
tions of ATZ metabolites in most of the
urine samples tested, we are uncertain what,
if any, health effects result from these levels
of exposure. In general, animal dosing stud-
ies that have investigated health effects
(Ashby et al. 2002; Cooper et al. 1996,
2000) have used doses much larger than
those to which we could assume (from back
calculation) participants were exposed in our
study. Further studies evaluating health out-
comes at typical human exposure levels
are warranted.
Conclusions
We have clearly been underestimating expo-
sure to ATZ-related metabolites in the U.S.
population and in other selected studies.
Our newer data are more in line with expo-
sures we might expect to see based upon
ATZ use and environmental persistence. It
is likely that multiple metabolites must be
measured to accurately classify exposure cat-
egories. Although DACT appeared to be the
predominant metabolite detected in each
exposure category, the interperson variations
in its concentrations were consistently about
30%. Regardless, DACT and DEA appear
to be the most important metabolites to
measure to evaluate exposures to ATZ-
related chemicals.
Clearly, exposure to ATZ or its degra-
dates appears more pervasive than previously
believed; however, more data are needed to
confirm this observation. Where measures
exist to mitigate or lessen exposures to bio-
logically active ATZ degradates such as the
use of high efficiency filters in municipal
water systems or other mitigation strategies
for pond and surface waters (Acosta et al.
2004; Agdi et al. 2000), they should be used
to ensure the best protection of public
health.
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Figure 5. Average percent contribution of each metabolite to the total atrazine-related metabolite level for
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atrazine mercapturate; DACT, diaminochlorotriazine; DEA, desethylatrazine; DEA-OH, hydroxydesethyl-
atrazine; DIA, desisopropyl atrazine. 
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